Malaysiakini
ENBM中文TA
Sign In
Subscribe
  • LifetimeACTIVEINACTIVEEXPIRED
  • Registered on:Renews on:Expires on:
    ACTIVEINACTIVEEXPIRED
  • Subscribe
  • Renew
  • Extend Subscription
  • Settings
  • Contact Support
  • Sign Out
  • Latest
  • Videos
  • Opinions
  • Yoursay
  • Featured
  • Kini News Lab
  • KiniGuide
  • Sustainability
  • Events
  • Collab Content
  • TopTech
  • Our Team
  • Privacy Policy
  • Terms of Service
  • Advertise with us
  • Careers
  • Email
  • WhatsApp
  • File a complaint
  • Address
Malaysiakini
user
Sign In
Subscribe
ENBM中文TA
  • Latest
  • Videos
  • Opinions
  • Yoursay
  • Featured
  • Kini News Lab
  • KiniGuide
  • Sustainability
  • Events
  • Collab Content
  • TopTech
  • Our Team
  • Privacy Policy
  • Terms of Service
  • Advertise with us
  • Careers
  • Email
  • WhatsApp
  • File a complaint
  • Address
ENBM中文TA

      ANNOUNCEMENT

      He was the sole candidate proposed for the post during a state committee meeting.

      He was the sole candidate proposed for the post during a state committee meeting.

      Covid-19 vaccine trial Brazil volunteer dies but trial to continue
      Malaysiakini
      News
      Covid-19 vaccine trial Brazil volunteer dies but trial to continue

      Covid-19 vaccine trial Brazil volunteer dies but trial to continue

      ReutersPublished: Oct 22, 2020 12:41 AM | Updated: Oct 22, 2020 2:20 AM

      Brazilian health authority Anvisa said on Wednesday that a volunteer in a clinical trial of the Covid-19 vaccine developed by AstraZeneca and Oxford University had died but added that the trial would continue.

      Oxford confirmed the plan to keep testing, saying in a statement that after careful assessment “there have been no concerns about safety of the clinical trial.”

      Vaccine hesitancy 'no big deal' in Covid-19 fight – expert

      Vaccine hesitancy 'no big deal' in Covid-19 fight – expert

      Trial of antibody drug Trump touted as Covid-19 'cure' paused over safety concern

      Trial of antibody drug Trump touted as Covid-19 'cure' paused over safety concern

      Russia's Covid-19 vaccine showed antibody response in initial trials

      Russia's Covid-19 vaccine showed antibody response in initial trials

      It’s dog eat dog in the world of Covid-19 vaccines

      It’s dog eat dog in the world of Covid-19 vaccines

      Scientists ask: Without trial data, how can we trust Russia's Covid vaccine?

      Scientists ask: Without trial data, how can we trust Russia's Covid vaccine?

      'At wartime speed', China leads COVID-19 vaccine race

      'At wartime speed', China leads COVID-19 vaccine race

      • comments0
      • facebook
      • whatsapp
      • x
      • comments0
      • facebook
      • whatsapp
      • x
      Related reports6

      Vaccine hesitancy 'no big deal' in Covid-19 fight – expert

      16-10-2020

      Trial of antibody drug Trump touted as Covid-19 'cure' paused over safety concern

      14-10-2020

      Russia's Covid-19 vaccine showed antibody response in initial trials

      05-09-2020

      It’s dog eat dog in the world of Covid-19 vaccines

      30-07-2020

      Scientists ask: Without trial data, how can we trust Russia's Covid vaccine?

      12-08-2020

      'At wartime speed', China leads COVID-19 vaccine race

      07-07-2020
      View Comments0

      Comments0

      By posting a comment, you agree to our Commenting Terms and Conditions as stipulated in full here.

      Do's and don'ts when posting comments in Malaysiakini

      TERMS & CONDITIONS

      Foul language, profanity, vulgarity, slanderous, personal attack, threatening, sexually-orientated comments or the use of any method of communication that may violate any law or create needless unpleasantness will not be tolerated. Antisocial behaviour such as "spamming" and "trolling" will be suspended. Violators run the risk of also being blocked permanently.

      REPORT VIOLATORS

      Please use the report feature that is available below each comment to flag offending comments for our moderators to take action. Do not take matters in your own hands to avoid unpleasant and unnecessary exchanges that may result in your own suspension or ban.

      NOTICE

      Our commenting system is still under development. We have taken note of feedback provided.

      Subscriber-only space:

      Are you a subscriber?

      Sign In

      Not yet a subscriber?

      Subscribe

      3200 characters remaining

      Pending comments0

      Are you sure you want to delete this comment?

      This action cannot be undone.

      Report this comment

      500 characters remaining
      mk-logo
      • whatsapp
      • telegram
      • youtube
      • facebook
      • x
      • instagram
      • tiktok
      • linkedin
      • About Us
      • Our Team
      • Privacy Policy
      • Terms of Service
      • Advertise with Us
      • Careers
      • Archive
      • Digital Network
      • KiniTV
      • FG Media
      • RSS Feeds
      • News
      • Opinion
      • Letters
      Contact Editorial
      envelopeeditor@malaysiakini.com
      Contact Subscription/Tech Support
      telephone+6017-323 0707
      envelopesubscribe@malaysiakini.com
      • Advertising
      • advertise@malaysiakini.com
      • advertise@fgmedia.my
      Mkini Dotcom Sdn Bhd
      (199901014818 / 489718-U)No. 9, Jalan 51/205A, Off Jalan Tandang, 46050 Petaling Jaya, Selangor
      Contact Editorial
      envelopeeditor@malaysiakini.com
      Contact Subscription/Tech Support
      telephone+603-7770 0017
      envelopesubscribe@malaysiakini.com
      @Kini
      No. 9, Jalan 51/205A, Off Jalan Tandang, 46050 Petaling Jaya, Selangor